Evidence map›Paper›PMID 42488174›Full record

ReviewSleep advances : a journal of the Sleep Research Society2026

Guidelines for daily sodium intake: a counterpoint to the current recommendation for low sodium intake.

Andrew Mente

Abstract readReview
In one paragraph

Review in Sleep advances : a journal of the Sleep Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Andrew MentePopulation Health Research Institute and Hamilton Health Sciences, and Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0001-6879-7675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several health organizations suggest that people should consume less sodium, aiming for an intake below 2.3 g per day on the premise that lowering sodium intake will lower blood pressure and, in turn, reduce the incidence of cardiovascular disease. However, these guidelines were created without effective means of maintaining low-sodium diets in real life, and strong evidence is lacking that shows low sodium intake leads to fewer cardiovascular events compared with average intake levels. This review evaluates whether the advice to consume less sodium is backed by solid evidence. It argues that most people consume a moderate amount of sodium (3 to 5 g per day), which is associated with the lowest risk of cardiovascular disease, and recommends a target below 5 g per day. Results from large randomized controlled trials evaluating the effect of sodium reduction on clinical events and mortality are awaited. This is particularly relevant in clinical practice, where sodium-containing medications such as sodium oxybate (SO), a mainstay in narcolepsy treatment, contribute to daily intake but are not considered by sodium guidelines. Clinicians should evaluate each patient's total sodium intake from both diet and medications and make personalized recommendations based on their cardiovascular and renal risk profile.

Indexed as

cardiovascular diseaseguidelinesmedicationsnarcolepsypharmacologicsodiumsodium oxybate

Identifiers

PMID42488174
PMCPMC13388325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.